Stay updated on SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page.
    Difference
    0.0%
    Check dated 2025-11-24T21:19:06.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and potential updates/response delays has been removed from the page. This change does not affect the trial details, eligibility criteria, or study results presented on the NCT03238027 page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T18:44:02.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The changes are limited to layout/formatting with no new eligibility criteria, endpoints, locations, or study status updated. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:17:51.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Version bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.
    Difference
    1%
    Check dated 2025-10-06T04:14:59.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.0%
    Check dated 2025-09-28T23:34:08.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed. No substantive changes to core content, pricing, stock, or time-related information.
    Difference
    0.1%
    Check dated 2025-09-14T09:48:13.000Z thumbnail image

Stay in the know with updates to SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.